INTERNATIONAL PATENT: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED FILES APPLICATION FOR "DOSAGE REGIMENS FOR CAMLIPIXANT IN TREATING CHRONIC COUGH"

GENEVA, April 18 -- GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED (GSK Medicines Research CentreGunnels Wood RoadStevenage SG1 2NY) filed a patent application (PCT/EP2025/078902) for "DOSAGE REGIMENS FOR CAMLIPIXANT IN TREATING CHRONIC COUGH" on Oct 08, 2025. With publication no. WO/2026/078027, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHAURET, Nathalie (c/o GSKGSK Medicines Research CentreGunnels Wood RoadStevenage SG1 2NY), GAHIR, Sarabjit Singh (c/o GSKGSK Medicines Research CentreGunnels Wood RoadStevena...